Dose-response: Exercise Therapy on Hip Osteoarthritis
Primary Purpose
Osteoarthritis, Hip
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
High-Dosage Exercise Therapy
Low-Dosage Exercise Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Osteoarthritis, Hip focused on measuring Exercise therapy
Eligibility Criteria
Inclusion Criteria:
- At least three month since debut of the disease
- Age above 45 years
- Ability to complete the intervention
Exclusion Criteria:
- Pain above 4 on VAS during gait
- Pregnancy
- Autoimmune disease
- Cardiovascular disease
- Respiratory disease
- Metabolic disease
- Neurological signs
- Planned hip-replacement surgery within the next year
- Received exercise therapy within the last 3 months
Sites / Locations
- Fysioterapitjenesten i Ørsta
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
High-dosage-group
Low-dosage-group
Arm Description
Outcomes
Primary Outcome Measures
WOMAC Index of Osteoarthritis (questionnaire)
WOMAC Index of Osteoarthritis (questionnaire)
Secondary Outcome Measures
HAD questionnaire
Tampa Scale for Kinesiophobia
Squats
Number of squats completed in 30 seconds.
Stairs
Time used to walk up and down 12 steps.
Full Information
NCT ID
NCT01700933
First Posted
October 1, 2012
Last Updated
September 19, 2017
Sponsor
Norwegian University of Science and Technology
1. Study Identification
Unique Protocol Identification Number
NCT01700933
Brief Title
Dose-response: Exercise Therapy on Hip Osteoarthritis
Official Title
Dose-response: Exercise Therapy on Hip Osteoarthritis, a Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
September 2012 (Actual)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Osteoarthritis is a common disease that causes muscle weakness, stiffness and instability. The disease reduces the opportunities for an active lifestyle. Exercise Therapy provides a well-documented effect on pain and function in patients with osteoarthritis of the hip. It is sought an optimal dose of exercise, in which this study will help to investigate.
We hypothesize that an exercise program designed to have a high number of repetitions will benefit the outcome of the training in a more positive way than a low-repetition based program.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Hip
Keywords
Exercise therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
35 (Actual)
8. Arms, Groups, and Interventions
Arm Title
High-dosage-group
Arm Type
Active Comparator
Arm Title
Low-dosage-group
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
High-Dosage Exercise Therapy
Intervention Description
Structure of the exercise program done three times per week, for eight weeks:
5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.)
Intervention Type
Other
Intervention Name(s)
Low-Dosage Exercise Therapy
Intervention Description
Structure of the exercise program done three times per week, for eight weeks:
5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.)
Primary Outcome Measure Information:
Title
WOMAC Index of Osteoarthritis (questionnaire)
Description
WOMAC Index of Osteoarthritis (questionnaire)
Time Frame
0 weeks, 8 weeks, 6 months postinterventional
Secondary Outcome Measure Information:
Title
HAD questionnaire
Time Frame
0 weeks, 8 weeks, 6 months postinterventional
Title
Tampa Scale for Kinesiophobia
Time Frame
0 weeks, 8 weeks, 6 months postinterventional
Title
Squats
Description
Number of squats completed in 30 seconds.
Time Frame
0 weeks, 8 weeks, 6 months postinterventional
Title
Stairs
Description
Time used to walk up and down 12 steps.
Time Frame
0 weeks, 8 weeks, 6 months postinterventional
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
At least three month since debut of the disease
Age above 45 years
Ability to complete the intervention
Exclusion Criteria:
Pain above 4 on VAS during gait
Pregnancy
Autoimmune disease
Cardiovascular disease
Respiratory disease
Metabolic disease
Neurological signs
Planned hip-replacement surgery within the next year
Received exercise therapy within the last 3 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Håvard Østerås
Organizational Affiliation
Norwegian University of Science and Technology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fysioterapitjenesten i Ørsta
City
Ørsta
ZIP/Postal Code
6154
Country
Norway
12. IPD Sharing Statement
Citations:
PubMed Identifier
28532870
Citation
Osteras H, Paulsberg F, Olsen SE, Osteras B, Torstensen TA. Effects of medical exercise therapy in patients with hip osteoarthritis: A randomized controlled trial with six months follow-up. A pilot study. J Bodyw Mov Ther. 2017 Apr;21(2):284-289. doi: 10.1016/j.jbmt.2016.06.016. Epub 2016 Jul 5.
Results Reference
result
Learn more about this trial
Dose-response: Exercise Therapy on Hip Osteoarthritis
We'll reach out to this number within 24 hrs